Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study
Sun公司雷珠单抗生物类似药治疗新生血管性年龄相关性黄斑变性的疗效、安全性和免疫原性:一项3期双盲对照研究
期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-024-00883-5
Ghosh, Asim K; Nikumbh, Usha S; Shukla, Chaitanya K; Laul, Rohit S; Dixit, Abhishek; Mahapatra, Santosh K; Nayak, Sameera; Shah, Urmil M; Parwal, Sandeep; Venkatapathy, Narendran; Radhakrishnan, Natasha; Kelgaonkar, Anup; Saxena, Sandeep; Mishra, Divyansh; Dave, Vivek Pravin; Khan, Perwez; Saswade, Manojkumar R; Shantilal, Malli S; Ramasamy, Kim; Sreekanta, Smitha; Rajurkar, Mandodari; Doshi, Maulik; Behera, Sapan; Patel, Piyush; Dhawan, Shilpi; Lakhwani, Lalit